TN2013000503A1 - Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia - Google Patents
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaInfo
- Publication number
- TN2013000503A1 TN2013000503A1 TNP2013000503A TN2013000503A TN2013000503A1 TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1 TN P2013000503 A TNP2013000503 A TN P2013000503A TN 2013000503 A TN2013000503 A TN 2013000503A TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treatment
- piperazino
- deuterated
- schizophrenia
- indanes
- Prior art date
Links
Abstract
The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161537103P | 2011-09-21 | 2011-09-21 | |
PCT/IB2012/001386 WO2012176066A1 (en) | 2011-06-20 | 2012-06-19 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2013000503A1 true TN2013000503A1 (en) | 2015-03-30 |
Family
ID=54359615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2013000503A TN2013000503A1 (en) | 2011-09-21 | 2013-12-03 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2013000503A1 (en) |
-
2013
- 2013-12-03 TN TNP2013000503A patent/TN2013000503A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013014978A (en) | Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1- yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia. | |
IN2014DN09434A (en) | ||
PH12015501404B1 (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
MX2013014849A (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia. | |
MX365939B (en) | Nuclear transport modulators and uses thereof. | |
PH12014501967A1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
GB201111485D0 (en) | Drug composition and its use in therapy | |
TN2014000001A1 (en) | A new therapeutical composition containing apomorphine as active ingredient | |
MX344846B (en) | Combination of active loaded granules with additional actives. | |
MX2014002395A (en) | Novel rock kinase inhibitors. | |
GB201115977D0 (en) | Neurodevelopmental disorders | |
TN2013000503A1 (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
MY166773A (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
EP3064201A4 (en) | Pharmaceutical composition for preventing and treating central nervous system diseases containing fluoxetine and vitamin c as active ingredients | |
IN2013MU01239A (en) | ||
GB201111427D0 (en) | Novel bisindolylmaleimides, pan-pkc inhibitors |